CLEVELAND BIOLABS INC 4
4 · CLEVELAND BIOLABS INC · Filed Feb 27, 2015
Insider Transaction Report
Form 4
SALUCK RANDY S.
Director
Transactions
- Purchase
Common Stock, par value $0.005 per share
2015-02-25$3.42/sh+1,891$6,468→ 6,116 total(indirect: Held by Mortar Rock, L.P.)
Footnotes (1)
- [F1]Mr. Saluck is a managing member of Mortar Rock Capital Management, LLC, which manages Mortar Rock, L.P.